Insider Selling: Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) CEO Sells 7,245 Shares of Stock

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) CEO Vininder Singh sold 7,245 shares of the stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $1.61, for a total value of $11,664.45. Following the sale, the chief executive officer now owns 2,385,201 shares of the company’s stock, valued at approximately $3,840,173.61. This represents a 0.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Vininder Singh also recently made the following trade(s):

• On Thursday, April 3rd, Vininder Singh sold 27,958 shares of Bullfrog AI stock. The stock was sold at an average price of $1.44, for a total value of $40,259.52.

Bullfrog AI Price Performance

Shares of Bullfrog AI stock opened at $1.30 on Friday. The stock has a 50-day simple moving average of $2.28 and a 200-day simple moving average of $2.34. Bullfrog AI Holdings, Inc. has a 52-week low of $1.23 and a 52-week high of $4.84. The firm has a market cap of $12.24 million, a price-to-earnings ratio of -1.53 and a beta of 0.33.

Bullfrog AI (NASDAQ:BFRG) last posted its earnings results on Friday, March 14th. The company reported ($0.18) EPS for the quarter.

Institutional Investors Weigh In On Bullfrog AI

A number of large investors have recently bought and sold shares of BFRG. Geode Capital Management LLC lifted its position in shares of Bullfrog AI by 31.0% in the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after buying an additional 11,140 shares during the last quarter. Two Sigma Securities LLC bought a new position in shares of Bullfrog AI in the 4th quarter valued at approximately $41,000. Finally, Raymond James Financial Inc. bought a new position in shares of Bullfrog AI in the 4th quarter valued at approximately $30,000. 0.96% of the stock is currently owned by institutional investors.

About Bullfrog AI

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.